Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic-induced Disruption of the Maternal and Infant Microbiota and Adverse Health Outcomes - The ABERRANT Study

NCT04091282 is registered in ClinicalTrials.gov with University of Fribourg as lead sponsor.

NCT NCT04091282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04091282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic-induced Disruption of the Maternal and Infant Microbiota and Adverse Health Outcomes - The ABERRANT Study
Lead sponsor
University of Fribourg
Phase
Observational
Overall status
Unknown status
Start date
January 25, 2020
Completion date
December 30, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic disruption, microbiota